Sector Chart Matinas BioPharma Holdings, Inc.
Stocks
MTNB
US5768103039
Biotechnology & Medical Research
|
Market Closed -
NYSE
16:10:00 2026-09-28 EDT
|
5-day change | 1st Jan Change | ||
| 2.530 USD | +5.42% |
|
+5.15% | -71.22% |
| 08-20 | Top Premarket Decliners | MT |
| 08-13 | Matinas BioPharma Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 2.35M | - | - | - | - | - |
| 72.26B | |||||
| 60.24B | |||||
| 27.73B | |||||
| 25.73B | - | ||||
| 24.75B | - |
Select your edition
All financial news and data tailored to specific country editions
